Your session is about to expire
← Back to Search
Study Summary
This trial will assess whether the EFNEP program is a cost-effective way to improve chronic disease biomarkers. 500 adults in four states will be monitored over the course of a year, measuring things like BMI, blood pressure, and HbA1c. The study will use analytical techniques like cost-benefit analysis and multivariate analysis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently breastfeeding.I can speak and understand either English or Spanish.
- Group 1: EFNEP Group
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What results are researchers hoping to glean from this clinical exploration?
"This research project aims to measure changes in blood pressure from the baseline measurement up until 12 months after intervention. The secondary objectives will evaluate participant health status 6 months post-intervention via a specific questionnaire, alterations to EFNEP adult questionnaire responses over the same period of time, and pertinent demographic information at the conclusion of treatment."
Is it possible to become a participant in this research experiment?
"This clinical trial is accepting 500 applicants, aged 18 to 50 with chronic illnesses. Additionally, they must be self-sufficient and bilingual in both English and Spanish. Eligible participants' income should fall below 185% of the Federal Poverty Line."
How many healthcare facilities are conducting this experiment?
"Four clinical centres are offering this trial, including Washington State University in Pullman, University of Florida in Gainesville, and Colorado State University in Fort Collins. Additionally, another four medical sites are hosting the same study."
Does this research have any age restrictions, particularly for those aged 55 and up?
"The parameters for participation in this trial are between 18 to 50 years old. There are separate studies available for participants under the age of 18, and those over 65."
Are there openings available for participants of this experiment?
"Clinicaltrials.gov records that this investigation is actively searching for qualified applicants, the original posting of which was on September 26th 2022 and has recently been updated to October 3rd 2022."
What is the aggregate of participants in this clinical experiment?
"This trial necessitates 500 qualified patients to partake. Those who decide to join can do so at Washington State University in Pullman, WA or the University of Florida in Gainesville, FL."
Share this study with friends
Copy Link
Messenger